- Current report filing (8-K)
May 24 2010 - 4:43PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): May 24, 2010
ProUroCare
Medical Inc.
(Exact
Name of Registrant as Specified in its Charter)
|
|
|
|
|
Nevada
|
000-51774
|
20-1212923
|
|
(State
or other jurisdiction
|
(Commission
|
(IRS
Employer
|
|
of
incorporation)
|
File
Number)
|
Identification
No.)
|
|
|
|
6440 Flying Cloud Dr.,
Suite 101, Eden Prairie,
Minnesota 55416
|
|
(Address
of Principal Executive Offices) (Zip Code)
|
|
|
|
(952)
476-9093
|
|
(Registrant’s
Telephone Number, Including Area Code)
|
|
Not
Applicable
|
|
(Former
Name or Former Address, if Changed Since Last Report)
|
|
|
|
|
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the
following
provisions:
|
|
o
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
|
|
|
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|
|
|
|
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR
240.13e-4(c))
|
Item 8.01 Other
Events
On May
24, 2010, ProUroCare Medical Inc. issued a press release announcing that a
de novo
application for
market clearance was filed in accordance with Section 513(f)(2) of the Federal
Food, Drug and Cosmetic Act on May 21
st
for the
ProUroScan (PMI) system, following a May 19
th
meeting
with the FDA. The full text of the press release is set forth in
Exhibit 99.1 attached hereto and is incorporated by reference in this Current
Report on Form 8-K as if fully set forth herein.
Item
9.01 Financial Statements and Exhibits.
(a) Financial
statements: None
(b) Pro
forma financial information: None
|
|
(c)
|
Shell
Company
Transactions: None
|
(d) Exhibits: 99.1 Press
release dated May 24, 2010
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the Registrant has duly caused this Report on
Form 8-K to be signed on its behalf by the undersigned hereunto duly
authorized.
|
|
ProUroCare
Medical Inc.
|
|
|
|
|
|
|
|
|
|
Date:
May 24, 2010
|
By
|
/s/
Richard C.
Carlson
|
|
|
|
Richard C. Carlson
|
|
|
|
Chief Executive Officer
|
EXHIBIT
INDEX
|
Exhibit
No.
|
ITEM
|
|
|
|
|
99.1
|
Press
Release dated May 24, 2010
|
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jul 2023 to Jul 2024
